Step by Step
Asp
Aspergillus fumigatus — a ubiquitous mold
Aspergillus fumigatus is found virtually everywhere in the environment. On microscopy, it shows septate hyphae branching at 45-degree angles — a distinguishing feature from other molds. What disease it causes depends entirely on the host, not the organism itself, since the same mold produces three completely different presentations.
ABPA
Allergic bronchopulmonary aspergillosis — an allergic reaction
In patients with asthma or cystic fibrosis, inhaled Aspergillus spores don't invade tissue — instead they trigger an IgE-mediated allergic reaction in the airways, worsening asthma control and causing characteristic mucus plugging.
Ball
Aspergilloma — colonizing an old cavity
In a patient with a pre-existing lung cavity — most classically from prior tuberculosis, but also sarcoidosis — Aspergillus can colonize that empty space and grow into a visible "fungus ball" without truly invading surrounding tissue.
Inv
Invasive aspergillosis — the life-threatening form
In neutropenic patients — classically those with AML undergoing chemotherapy, or transplant recipients — Aspergillus becomes genuinely invasive, growing directly into blood vessels (angioinvasion) and causing hemorrhagic tissue infarcts. The classic imaging finding is the halo sign on CT chest. First-line treatment is voriconazole, with amphotericin B as an alternative.
A patient undergoing induction chemotherapy for AML becomes neutropenic and develops a fever; CT chest shows a halo sign — this is invasive aspergillosis, requiring urgent voriconazole treatment given the angioinvasive, life-threatening nature of the disease in this host.
Applied Walkthrough
1
A patient with AML is undergoing chemotherapy and becomes severely neutropenic.
2
They develop fever, and a CT chest shows a halo sign around a lung nodule.
3
Ask: which of the three Aspergillus presentations does this match? The neutropenic host and halo sign point specifically to invasive aspergillosis — a life-threatening, angioinvasive disease requiring urgent antifungal treatment (voriconazole first-line).
4
Contrast: if this same CT finding appeared in a patient with a history of tuberculosis and an old lung cavity, but no neutropenia, the presentation would instead be aspergilloma — colonization without true tissue invasion, a fundamentally less urgent situation.
Exam Application
Exams test matching each Aspergillus presentation to its host: ABPA in asthma/CF patients (allergic, IgE-mediated), aspergilloma in patients with pre-existing cavities like old TB (colonization, not invasion), and invasive aspergillosis in neutropenic patients (angioinvasive, halo sign, voriconazole treatment).
⚠ Common Trap
The most common trap is treating all three presentations as equally urgent or as the same disease process. Aspergilloma is essentially colonization of dead space and often doesn't require aggressive systemic antifungal therapy, while invasive aspergillosis is a true emergency requiring immediate treatment — confusing the two could mean under-treating a life-threatening infection or over-treating a stable colonization.
✓ Quick Self-Check
1. What does Aspergillus look like on microscopy?
Septate hyphae branching at 45-degree angles.
Tap to reveal / hide
2. What triggers ABPA, and in which patients does it occur?
An IgE-mediated allergic reaction to inhaled Aspergillus spores, occurring in patients with asthma or cystic fibrosis.
Tap to reveal / hide
3. What is an aspergilloma, and where does it typically form?
A fungus ball that colonizes a pre-existing lung cavity, most classically from prior tuberculosis.
Tap to reveal / hide
4. What patient population is at risk for invasive aspergillosis, and what is the classic CT finding?
Neutropenic patients (AML, transplant recipients); the classic finding is the halo sign.
Tap to reveal / hide
5. What is the first-line treatment for invasive aspergillosis?
Voriconazole, with amphotericin B as an alternative.
Tap to reveal / hide